| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $443K | -37.3% | +13.3% |
| Cost of Revenue | $206K | -20.2% | +25.6% |
| Gross Profit | $238K | -47.1% | +4.8% |
| R&D Expense | $74K | -14.0% | -8.6% |
| SG&A Expense | $847K | +14.0% | -2.8% |
| Operating Income | -$683K | -80.2% | +5.8% |
| Interest Expense | $190K | +108.8% | — |
| Net Income | -$785K | -69.2% | +1.6% |
| EPS (Basic) | -$0.01 | — | +0.0% |
| EPS (Diluted) | -$0.01 | — | +0.0% |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $198K | -54.4% | -2.0% |
| Accounts Receivable | $252K | -35.2% | +40.0% |
| Inventory | $244K | +3.0% | +225.3% |
| Current Assets | $779K | -33.8% | +38.6% |
| Total Assets | $788K | -33.6% | +37.3% |
| Current Liabilities | $3.1M | -3.3% |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$856K | -242.4% | — |
| Financing Cash Flow | $720K | +105.7% | — |
| +252.8% |
| Total Liabilities | $7.1M | +4.9% | +45.9% |
| Stockholders' Equity | -$6.3M | -13.1% | -47.0% |